Alterity’s ATH434 Gets FDA Fast Track for Multiple...
Category : ODD/BTA/FTA Status 6 May 2025Alterity Therapeutics has been granted Fast Track designation by the U.S. Food and Drug Administrati...
Odd Bta Fta Status
OKYO Pharma’s Urcosimod Gets FDA Fast Track for Co...
Category : ODD/BTA/FTA Status 5 May 2025OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company, announces that the US Food...
Baebies Gets FDA Breakthrough Status for Heparin M...
Category : ODD/BTA/FTA Status 26 April 2025Baebies, a North Carolina-based diagnostics company, has received Breakthrough Device Designation fr...
MHRA Review of UK Trial Applications Reveals New B...
Category : ODD/BTA/FTA Status 14 April 2025The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products...
Avidity’s Delpacibart Gets Japan Orphan Drug Statu...
Category : ODD/BTA/FTA Status 11 April 2025Avidity Biosciences, Inc, a biopharmaceutical company committed to delivering a new class of RNA the...
Latest Newsletter Post
-
ABLi Therapeutics Launches with Nov..
14 May 2025
-
Trixeo Aerosphere Approved in UK wi..
14 May 2025
-
Rein Therapeutics Begins Phase 2 RE..
14 May 2025
-
Abbisko to Present Phase 2 Irpagrat..
13 May 2025
-
Novo Nordisk Shares Positive Phase..
13 May 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com